The Cigna Group (NYSE:CI) Shares Purchased by Greenleaf Trust

Greenleaf Trust raised its stake in The Cigna Group (NYSE:CI) by 1.1% in the third quarter, HoldingsChannel reports. The fund owned 8,994 shares of the health services provider’s stock after purchasing an additional 100 shares during the period. Greenleaf Trust’s holdings in The Cigna Group were worth $3,116,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also bought and sold shares of CI. Cedar Wealth Management LLC acquired a new position in shares of The Cigna Group in the 1st quarter valued at $29,000. TruNorth Capital Management LLC purchased a new position in shares of The Cigna Group in the 2nd quarter valued at about $33,000. Ulland Investment Advisors LLC raised its holdings in The Cigna Group by 2,500.0% in the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after purchasing an additional 100 shares during the period. Thurston Springer Miller Herd & Titak Inc. purchased a new position in The Cigna Group during the second quarter worth approximately $66,000. Finally, Private Ocean LLC grew its holdings in The Cigna Group by 29.9% in the second quarter. Private Ocean LLC now owns 200 shares of the health services provider’s stock valued at $66,000 after purchasing an additional 46 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling

In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the company’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $342.68, for a total value of $922,151.88. Following the transaction, the director now owns 17,539 shares of the company’s stock, valued at $6,010,264.52. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on CI shares. JPMorgan Chase & Co. increased their target price on The Cigna Group from $435.00 to $438.00 and gave the company an “overweight” rating in a research report on Wednesday, August 21st. Jefferies Financial Group lifted their target price on shares of The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a research report on Tuesday, September 17th. Barclays raised their price target on shares of The Cigna Group from $393.00 to $405.00 and gave the company an “overweight” rating in a research note on Friday, August 2nd. Stephens reiterated an “overweight” rating and set a $410.00 price objective on shares of The Cigna Group in a research note on Friday, August 2nd. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $400.00 target price on shares of The Cigna Group in a research report on Wednesday. One investment analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, The Cigna Group currently has a consensus rating of “Buy” and a consensus target price of $392.79.

The Cigna Group Trading Up 0.0 %

Shares of CI opened at $317.61 on Thursday. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.73. The firm has a 50-day moving average price of $349.85 and a 200 day moving average price of $343.40. The Cigna Group has a 12-month low of $253.95 and a 12-month high of $370.83. The firm has a market capitalization of $90.22 billion, a P/E ratio of 26.08, a P/E/G ratio of 1.05 and a beta of 0.50.

The Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, August 1st. The health services provider reported $6.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.42 by $0.30. The Cigna Group had a net margin of 1.70% and a return on equity of 17.83%. The business had revenue of $60.52 billion during the quarter, compared to the consensus estimate of $58.30 billion. During the same quarter last year, the firm earned $6.13 EPS. The business’s revenue was up 24.6% compared to the same quarter last year. Sell-side analysts forecast that The Cigna Group will post 28.48 EPS for the current year.

The Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Stockholders of record on Wednesday, December 4th will be issued a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.76%. The Cigna Group’s dividend payout ratio is presently 45.98%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.